NaturalPedia > Bristol-myers Squibb

Quotes about Bristol-myers Squibb from the world's top natural health / natural living authors

 Email this page to a friend   |  Click here for FREE email alerts

page 1 of 3 | Next ->

"Which was nothing compared to the stock options held by the CEO of bristol-myers squibb, which amounted to $227 million. And it's not just the CEOs: in 2000, the average unexercised stock options of the top executives at Merck were $73 million; at bristol-myers squibb, $65 million; at Pfizer, $54 million; at Eli Lilly, $33 million." - Charles Barber, Comfortably Numb: How Psychiatry Is Medicating a Nation (Get the book.)

"Wagner has received research support from Abbott, bristol-myers squibb, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Organon, Pfizer, and Wyeth-Ayerst; has served as a National Institute of Mental Health consultant to Abbott, bristol-myers squibb, Cyberonics, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Novartis, Otsuka, Janssen, Pfizer, and UCB Pharma; and has participated in speaker's bureaus for Abbott, Eli Lilly, GlaxoSmithKline, Forest Laboratories, Pfizer, and Novartis.2 The study's principal statistician was Dr. Ruoyong Yang. Both he and another of the study's authors, Dr." - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.)

"There is a new magazine, bp (underwritten by Pfizer and bristol-myers squibb), offering hope for people suffering from bipolar disorder. Monk, a show about a detective with obsessive-compulsive disorder who uses his illness adaptively to perceive things that normal people can't, is one of the most popular programs on cable television and has received a gaggle of Screen Actors Guild, Emmy, and Edgar awards." - Charles Barber, Comfortably Numb: How Psychiatry Is Medicating a Nation (Get the book.) "And it's not just the CEOs: in 2000, the average unexercised stock options of the top executives at Merck were $73 million; at bristol-myers squibb, $65 million; at Pfizer, $54 million; at Eli Lilly, $33 million.5 Even after the woes that Big Pharma experienced between 2004 and 2007—the withdrawal of Vioxx from the market, the loss of half of the injectable flu vaccines because of quality control problems, and a growing public awareness of profiteering and an all-too-cozy relationship with the Bush administration—no one should worry unduly about the industry's fortunes." - Charles Barber, Comfortably Numb: How Psychiatry Is Medicating a Nation (Get the book.)

"Of those with high cholesterol, 6,595 agreed to participate in a five-year, randomized placebo-controlled trial of pravastatin, the "statin" marketed under the brand name Pra-vachol by the bristol-myers squibb Pharmaceutical Company, which funded the trial. That means that every morning for the five years, these men took a pill. For 3,302 men, that pill contained 40 mg of pravastatin, and for the remainder the morning pill contained a pharmacologically inert substance, a placebo. The main results are presented in Table 1." - Nortin M. Hadler MD, Worried Sick: A Prescription for Health in an Overtreated America (Get the book.)

"These are the gifts and payments he has received from these companies in the last two years: January 17, dinner and drinks at Daniel, compliments of Forest Labs, value three hundred dollars; January 23, fee for speaking about a new asthma drug, compliments of GlaxoSmithKline, two thousand dollars; February 12 to 15, educational conference in Aspen, Colorado, sponsored by Pfizer, Merck, and bristol-myers squibb, value of the corporate subsidies to Dr. Jones, twenty-five hundred dollars; and so on." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.) "In 2001 Peter Dolan, a young executive who had made his early mark promoting Jell-O for General Foods, became the chief executive of bristol-myers squibb. The drug company Novartis hired the Pepsi marketer Thomas Ebeling and by 2000 had given him responsibility for running its global pharmaceutical business. When Randall Tobias took over as the head of Eli Lilly in 1993, he had spent most of his career as an executive for the phone company AT&T." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.) "After one of Armstrong's Tour de France victories, the company paid for advertisements proclaiming, "This miracle is brought to you by bristol-myers squibb." However, the truth behind the discovery of the medicines that saved Armstrong got lost in the frenzy of international publicity as he appeared for Bristol-Myers on television shows like ABC's Good Morning America and Live with Regis and Kathie Lee." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.) "For example, Bristol-Myers Squibb's bestselling cancer drug Taxol was discovered by scientists funded through government grants. The federal government then paid to manufacture the drug and to test it in patients, before granting a license to Bristol-Myers to sell it. In fact, of the nation's twenty-one most important drugs introduced between 1965 and 1992, fifteen were developed using knowledge from federal-funded research, according to a report in 2000 by the Joint Economic Committee of Congress, then headed by Republican senator Connie Mack." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.)

"In one recent case, a Louisiana judge ordered bristol-myers squibb, the company that manufactures and distributes Prolixin, to pay $2 million to a fifty-two-year-old woman who developed severe and disabling tardive dyskinesia after taking the drug for five years. Among her symptoms were muscle spasms and abnormal movements of the face, neck, shoulders, and extremities, as well as impaired speech and breathing. More than thirty years ago, according to Dr." - Gary Null and Amy McDonald, The Food-Mood Connection: Nutrition-based and Environmental Approaches to Mental Health and Physical Wellbeing (Get the book.)

"In 2004 the Securities and Exchange Commission (SEC) ordered bristol-myers squibb to pay $ 150 million to settle charges that it inflated its revenue by $1.5 billion in 2000 and 2001. The penalty was one of the largest levied against a company accused of accounting fraud.26 The settlement concluded a two-year SEC investigation of the company, but the bad news for bristol-myers squibb didn't stop there. A separate criminal investigation by the U.S." - Peter Rost, The Whistleblower: Confessions of a Healthcare Hitman (Get the book.)

"However, the site does mention that the two nonprofit organizations participating in this educational initiative have a number of "corporate partners," namely AstraZeneca, Aventis, bristol-myers squibb, Eli Lilly, GlaxoSmithKline, Merck, Merck/Schering-Plough, Monarch, Novartis, Pfizer, and Wyeth. When corporate partners fund the flow of information, the message is likely to accentuate treatment strategies that are in their interest and downplay those that are not. For example, fewer than one-third of the diabetics in the United States get adequate exercise." - John Abramson, Overdosed America: The Broken Promise of American Medicine (P.S.) (Get the book.) "The FDA seemed particularly irked because, the letter said, it had sent two less severe letters to bristol-myers squibb for similar "overstated" and "unsubstantiated" claims in 2001. If stroke prevention is the goal, lowering cholesterol with a statin drug is hardly the first strategy we should turn to. According to the data presented by Giles at the CDC conference, an elevated cholesterol level increases the risk of stroke one-eighth as much as diabetes, one-eighth to one-sixteenth as much as elevated blood pressure, and less than a thirtieth as much as a sedentary lifestyle." - John Abramson, Overdosed America: The Broken Promise of American Medicine (P.S.) (Get the book.) "Andrew Bodnar, a senior vice president at bristol-myers squibb, summarized this issue when he told the New York Times, "In a science-driven organization, the notion of marketing versus science is really a false dichotomy." Disciplined science performed by impartial researchers and openly shared with professional colleagues and the public is often replaced with games of cat and mouse in which corporate sponsors do their best to hide both the ways that their scientific results have been spun, and the results that can't be spun." - John Abramson, Overdosed America: The Broken Promise of American Medicine (P.S.) (Get the book.) "The one thing we can know is that the denials of the evidence of such a relationship in the 2001 cholesterol guidelines and by the authors of the PROSPER article (sponsored by bristol-myers squibb) suggest that the principle "First do no harm," which should be fresh in our minds from the increased rate of breast cancer caused by HRT, seems, once again, to have been forgotten." - John Abramson, Overdosed America: The Broken Promise of American Medicine (P.S.) (Get the book.)

"Joining forces to provide the Nutrition in Medicine program and the Medical Nutrition Curriculum Initiative are no less than the Dannon Institute, the Egg Nutrition Board, the National Cattlemen's Beef Association, the National Dairy Council, Nestle Clinical Nutrition, Wyeth-Ayerst Laboratories, bristol-myers squibb Company and others. The reason that medical schools fail to teach medical students the truth about health is that drug companies fund their scholarships and want to create doctors who function as professional and legal drug pushers." - Susan E. Schenck, The Live Food Factor: The Comprehensive Guide to the Ultimate Diet for Body, Mind, Spirit & Planet (Get the book.)

"In 1992, the NIH licensed Taxol to bristol-myers squibb, which then generated $2 billion of revenue per year on the sale of the product. So again, quite a few blockbuster medications are clearly developed by public funding, academic medical centers, and foreign academic centers, whilst the pharmaceutical industry gets additional tax-advantages. So, in what are the pharmaceutical companies investing? Yes, in advertising, advertising, advertising. And in sales, sales, sales. The physicians are swamped with pharmaceutical sales representatives." - Kenneth W Thomas, Ron Gilbert, Gerd Schaller, Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel (Get the book.)

"Kathleen Slattery-Moschkau is a former rep who carried the bag for nine years for bristol-myers squibb and Johnson & Johnson before quitting to write and direct Side Effects, an independent film about a fictional drug rep. She recalls that the pressure on reps to hit their quotas was intense. "If Pfizer was having a dinner at a really nice restaurant, you had to come up with [Green Bay] Packers tickets—and a bus to the game," she says. As reps upped the gift-giving ante, doctors began feeling entitled to increasingly luxurious favors." - Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (Get the book.)

"But when Martin Keller, a psychiatrist at Brown University, and his colleagues published a study of an antidepressant manufactured by bristol-myers squibb, the conflict-of-interest disclosures were so extensive that Dr. Angell concluded she could not print the entire list in the paper version of the journal. Instead she put the information on the New England Journal of Medicine's website and then wrote an editorial with the stinging title "Is Academic Medicine for Sale?" - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.)

"The Dannon Institute, Egg Nutrition Board, National Cattlemen's Beef Association, National Dairy Council, Nestle Clinical Nutrition, Wyeth-Ayerst Laboratories, bristol-myers squibb Company, Baxter Healthcare Corporation and others have all joined forces to produce a Nutrition in Medicine program and the Medical Nutrition Curriculum Initiative.9'10 Do you think that this all-star team of animal foods and drug industries representatives is going to objectively judge and promote optimal nutrition, which science has shown to be a whole foods, plant-based diet that minimizes the need for drugs?" - T. Colin Campbell, Ph.D. and Thomas M. Campbell II, The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health (Get the book.)

"But others, such as bristol-myers squibb, which markets one of the least potent statins, Pravachol, insist patients glean little incremental benefit by reducing their LDL levels too much. Doctors, and their patients, are naturally interested if lower really is better. But pharma companies are usually reluctant to pit their drugs against competitors in head-to-head studies, unless they have reason to believe the results would favour their product." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.) "This pitted an 80mg daily dose of Pfizer's Lipitor against a 40mg daily dose of Bristol-Myers Squibb's Pravachol in 4,000 patients who had been hospitalized for either acute heart attacks or unstable angina. This was funded by BMS in an attempt to show that lower was not necessarily better. The BMS drug was designed to reduce LDL cholesterol to 100, which according to US guidelines, is the target level for such patients. In contrast, the high-dose Lipitor was designed to reduce levels to 70, substantially lower than the guidelines." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.) "Pharma company, bristol-myers squibb (BMS), was also thrown into some disarray because it had paid $2 billion for a 20% stake in ImClone plus the US marketing rights to Erbitux, the jewel in its crown. Even with all the due diligence a company the size of BMS can afford, still pharmaceuticals are a seriously risky business. All that changed, of course, when the concerns to do with the study design had been ironed out and Erbitux did get its first licence." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.) "The drug, Bristol-Myers Squibb's cholestyramine, had to be sprinkled onto food making it taste ghastly, and two-thirds of those taking it reported side effects of constipation, gas, heartburn and bloating. After seven years of this ordeal, 30 of the 1,900 people taking the drug had suffered a fatal heart attack compared to 38 in the control group. This does correlate with a 25% drop in risk because the difference, eight, is roughly 25% of 38. But it took seven years and an awful lot of effort and expense to 'save' eight lives." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.)

"Of those with high cholesterol, 6,595 agreed to participate in a five-year randomized placebo controlled trial of pravastatin, the statin marketed under the brand name Pravachol by the sponsor for the trial, the bristol-myers squibb Pharmaceutical Company. Every morning for five years, these men took a pill. For 3,302 men, that pill contained 40 mg of pravastatin; for the remainder, the pill contained a pharmacologically inert substance, a placebo." - Nortin M. Hadler, The Last Well Person: How to Stay Well Despite the Health-Care System (Get the book.)

"The bristol-myers squibb antidepressant Serzone (nefazodone) was first made available to both U.S. and Canadian citizens in 1994. Numerous drugs that have been approved for use by the FDA were later found to cause liver damage. (All drugs are, in one sense, poisons. It is the liver's job to filter out and break down any "poison" such as alcohol and illegal or legal drugs. Hence, regular intake of any of these has the potential to harm the liver and to a lesser extent, the kidneys, the body's other filter.) But the warnings about Serzone were particularly clear." - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.) "The study itself was paid for by bristol-myers squibb. That is not the end of the story. By 2002 the New England Journal of Medicine found that obtaining reviewers without financial ties to drug companies was so difficult they felt it necessary to change their conflict-of-interest policy. Today it no longer states that there cannot be any financial interest in the drugs being evaluated. Today the policy states that there cannot be any "significant" interest, meaning amounts exceeding $10,000 per year." - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.)

"In 2000 the CEO of bristol-myers squibb sent urgent messages to all of his company's top managers to "donate the maximum" to the Bush campaign, $1,000 individually and $1,000 in their spouse's name; the company itself ponied up $2 million. In 2002, seeing that some form of prescription drug bill was inevitable, Holmer and his companies targeted $26 million for local congressional races. They also ratcheted up old-fashioned, buttonhole lobbying. By 2002 there were six pharma lobbyists for every sitting U.S. senator, a kind of political day care for potentially errant legislators." - Greg Critser, Generation Rx: How Prescription Drugs are Altering American Lives, Minds, and Bodies (Get the book.) "Even its manufacturer, bristol-myers squibb, claimed that Serzone was mainly for people for whom all of the other antidepressants did not work. Yet its hepatotoxicity was clear, and reports during the years immediately after its release, both at the FDA and at Squibb, indicated that people were suffering from it. Worse, Serzone was a potent liver enzyme inhibitor, which meant that it prevented the liver from processing other drugs properly, leading to further injury from everything from statins to other central nervous system drugs." - Greg Critser, Generation Rx: How Prescription Drugs are Altering American Lives, Minds, and Bodies (Get the book.) "Consider Raymond Sacchetti, the head of "compliance and persistency" at bristol-myers squibb. Sacchetti had made a study of patient compliance and what he called "adherence marketing," and he could prove that DTC resulted in better persistence. "If you do a hundred sixty days of DTC ads," he told the audience, "well, you get a thirty-five percent rate of compliance after twelve months. But if you do two hundred fifty days of DTC ads, you get sixty-five percent!" - Greg Critser, Generation Rx: How Prescription Drugs are Altering American Lives, Minds, and Bodies (Get the book.)

page 1 of 3 | Next ->

FAIR USE NOTICE: The research quoted here is provided under the protection of Fair Use provisions and published by the 501(c)3 non-profit Consumer Wellness Center for the purposes of public comment and education. Authors / publishers may submit books for consideration of inclusion here.

TERMS OF USE: Read full terms of use. Citations of text from NaturalPedia must include: 1) Full credit to the original author and book title. 2) Secondary credit to the Natural News Naturalpedia as a research resource and a link to www.NaturalPedia.com

This unique compilation of research is copyright (c) 2008, 2009 by the non-profit Consumer Wellness Center.

ABOUT THE CREATOR OF NATURALPEDIA: Mike Adams, the creator of NaturalPedia, is the editor of NaturalNews.com, the internet's top natural health news site, creator of the Honest Food Guide (www.HonestFoodGuide.org), a free downloadable consumer food guide based on natural health principles, author of Grocery Warning, The 7 Laws of Nutrition, Natural Health Solutions, and many other books available at www.TruthPublishing.com, creator of the earth-friendly EcoLEDs company (www.EcoLEDs.com) that manufactures energy-efficient LED lighting products, founder of Arial Software (www.ArialSoftware.com), a permission e-mail technology company, creator of the CounterThink Cartoon series (www.NaturalNews.com/index-cartoons.html) and author of over 1,500 articles, interviews, special reports and reference guides available at www.NaturalNews.com. Adams' personal philosophy and health statistics are available at www.HealthRanger.org.